IGF2BP3 As a Prognostic Biomarker and Regulator of Metastasis in Merkel Cell Carcinoma.

JID Innov · 2025 · PMC11951866 · PMID 40162116

Europe PMC DOI

hedged sentence

0.0553

closest p · 1.1× alpha

0.0553

boldest claim

The sentences

did not reach statistical significanceP = .0553so close (0.05 < p ≤ 0.1)

In this cohort, IGF2BP3 expression was higher in stage IV tumors than in stages I–II, but this difference did not reach statistical significance ( P = .0553; Supplementary Figure S4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.